A report published yesterday in Clinical Infectious Diseases describes a new SARS-CoV-2 mutation that confers resistance to the COVID-19 antiviral drug remdesivir in two persistently infected kidney transplant recipients treated with immunosuppressive drugs.
Illnesses have been reported in 2 more locations.
The WHO says the outbreak location and its mobile population pose a risk of further spread.
The outbreak includes 1 confirmed fatal case and 8 suspected infections in people who are receiving medical care.
Within days of confirming a new Ebola case in North Kivu province, medical teams in the Democratic Republic of the Congo (DRC) today launched an Ebola vaccination campaign in Beni, the area where the fatal case was reported.
On Twitter, the World Health Organization (WHO) said it provided 200 vaccine doses and is supporting the country's ring vaccination campaign.
Over the weekend, the World Health Organization (WHO) African regional office reported a suspected Ebola case in the Democratic Republic of the Congo's (DRC's) North Kivu province, and today an official from the country's national lab confirmed the finding, according to media reports.
A study of hospitalized pneumonia patients in Denmark found similar outcomes between short-course and prolonged-course antibiotic therapy, Danish researchers reported yesterday in Clinical Microbiology and Infection.
Completion of a primary COVID-19 vaccination series after recovery from infection was tied to half the risk of reinfection in the pre-Omicron variant era, according to a study published today in JAMA Network Open.
An antibiotic stewardship intervention for asymptomatic bacteriuria (ASB) was associated with a reduction in urine cultures and antibiotic use at four Veterans Affairs (VA) hospitals, researchers reported today in JAMA Network Open.
A new study published in Applied Economics Letter estimates long COVID symptoms have forced 80,000 UK residents out of employment as of March of this year.
The estimate is based on data that show 5.5% of people infected with COVID-19 will develop chronic illness symptoms that limit their activity, including shortness of breath, brain fog, and headaches.
